Tuesday, 29 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14499
Articles
Company
Drug
Bio-Thera Solutions Terminates BAT3306 Trial Amid Biosimilar Policy Shifts
May 27, 2025
Company
Drug
Fosun Pharma’s HLX22 Granted Orphan Drug Designation by EU Commission
May 27, 2025
Company
Drug
UCB Launches Rystiggo in China for Generalized Myasthenia Gravis
May 27, 2025
Company
Drug
Bio-Thera Solutions’ BAT2206 Biosimilar of Stelara Gains FDA Approval
May 27, 2025
Policy / Regulatory
Hainan Introduces New Pricing Rules for Digital Therapeutics Effective June 1
May 27, 2025
Company
Drug
Kanghong Pharma Wins NMPA Approval for KH617 in Glioblastoma Trial
May 27, 2025
Company
Deals
Shandong Kanghua Biotechnology Announces IPO Plans on Beijing Stock Exchange
May 27, 2025
Company
Deals
Salubris Pharma Inks Licensing Deal for Gowell’s GW906 in Greater China
May 27, 2025
Company
Deals
Walvax Biotechnology Secures Exclusive Rights to Notitia’s Gut Microbiota Therapy
May 26, 2025
Company
Drug
Guangdong Zhongsheng Wins Peking University People’s Hospital Nod for RAY1225 Phase III Trials
May 26, 2025
Company
Drug
Jemincare’s Irinotecan Liposome Injection Gains NMPA Approval for Pancreatic Cancer
May 26, 2025
Company
Drug
Novo Nordisk’s Wegovy Demonstrates Early Cardioprotective Effects in SELECT Trial
May 26, 2025
1
2
…
357
358
359
360
361
…
1,208
1,209
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
